Lovely movement

What’s triggered this

Slowly and steady

Good to see some recovery lets hope for a rocket for the 2027 year

Anyone got info

What’s the crack with this fkn stock.

Beyond a joke

The management need to get their act together quickly.

Are these ever recovering

These shares are shite bought in at 8 dollars down about 80% can’t bring myself to sell will we see a recovery ever

This is an absolute dud

Can’t believe I broke my rule on buying shite.

Absolute crap

These shares are absolute crap, been at a loss for ages, wish I never bought them.

What the hell

This is doing my head in.

What’s happening ?

I reckon news really soon , hopefully

Poor

What’s a total !@#$ show these stocks are been at a total loss for ages

Im in

In at 1.42 Wish me luck (if there’s any)!

VOLUME IS UP⬆️⬆️⬆️

Little spike and looking at the volume there will be another soon. No merger yet but I keep saying we only need to stay above $1 for another week and then we have a high percentage of merger talks thats when we see a rocket. But thats wont be the half of it any of these private companies are looking to merge. And let me tell you they are looking for a shell. Then this is a game changer. It does have to happen to be a game changer but QNCX has the best fit out of all the shells. 1. Xaira Therapeutics Backing: Launched in April 2024 with $1 billion in committed funding from major firms like ARCH Venture Partners and Foresite Capital. Why it fits: It is one of the only private biotechs to actually hit the $1 billion funding mark in a single launch. They focus on AI-driven drug discovery, a high-value sector that often attracts significant investor interest. 2. Kailera Therapeutics Backing: Has raised approximately $1 billion in total private funding as of late 2025/early 2026, including a massive $600 million Series B. Industry Focus: Obesity (GLP-1) and related metabolic diseases. Status: While they recently launched an IPO roadshow, many companies in this sector keep a "dual-track" strategy, meaning they evaluate reverse mergers with shells like QNCX simultaneously with IPO plans. 3. Eikon Therapeutics Backing: Valued at approximately $3.2 billion with significant private backing from investors like T. Rowe Price and Canada Pension Plan Investment Board. Industry Focus: Advanced microscopy and drug discovery. Recent Activity: They recently completed an IPO in early 2026, but were long considered a primary candidate for a major public market entry.

Can we pls see news today !!

Honestly what was the point of clearing debt and doing a 10-1 split, if this was gonna die and if we weren’t gonna stay above $1, hopefully there’s news today or tomorrow, or consider this dead

RS completed

the halt is over, let's push

RS 1-for-10 if a merger is on the cards

Ive been doing a little digging and found some previous similar scenarios all available for you to look the Internet. Because Its blown my mind how $5.5m has been paid if they expect to go bankrupt. Therefore i think there is something in the pipeline. Everything is strictly private and no info to be given. So asking AI to find me similar scenarios 1. MDGL 2. IRON 3. TECX 4.LH 5. BKNG The first 3 have similar failed drug trail and then were merged after RS as a shell and not failed company, they are all above $30.72 and MDGL is $527. I believe we have potential to be sitting pretty here. Im not selling and if it stays above $1 then we look like were have a good start. Pretty sure it has to hold for an actual handshake but this could be one of them gems. Fingers crossed. And for all you holding im with you. NFA